Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Virility Medical's primary product?
- Virility Medical has developed the world’s first clinically proven wearable device based on muscle stimulation, scientifically engineered to delay ejaculation. This technology enhances men’s ability to contract pelvic-floor muscles.
- When was Virility Medical founded?
- Virility Medical was founded in May 2016.
- How much funding has Virility Medical raised in total?
- Virility Medical has raised a total of $21,000,000 USD.
- Which investor participated in Virility Medical's Seed round in June 2016?
- NGT3 was an investor in Virility Medical's Seed round in June 2016.
- When did Virility Medical receive a grant from the IIA and for what amount?
- In June 2016, Virility Medical received a grant of $700,000 USD from the IIA.
- Which investor led Virility Medical's Series A round in February 2021?
- Arkin Tech led Virility Medical's Series A round in February 2021, with Almeda Ventures and NGT HealthCare II also participating.
- What was the most recent funding round for Virility Medical?
- Virility Medical's most recent funding round was an Undisclosed round in July 2022, which raised $10,000,000 USD. Migdal Insurance and Financial Holdings led this round, with Arkin Tech also participating.
- How many employees does Virility Medical currently have?
- Virility Medical currently has between 1 and 10 employees, with an exact count of 6.
- In what month and year was Virility Medical's technology solution to premature ejaculation introduced?
- In May 2024, Virility Medical introduced its technology solution to premature ejaculation.